Marijan Kočevar
University of Ljubljana
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marijan Kočevar.
European Journal of Medicinal Chemistry | 2011
Eva Vavříková; Slovenko Polanc; Marijan Kočevar; Kata Horváti; Szilvia Bősze; Jiřina Stolaříková; Kateřina Vávrová; Jarmila Vinšová
Several new fluorine-containing hydrazones were synthesized and screened for their in vitro antimycobacterial activity. Nine of these derivatives have shown a remarkable activity against MDR-TB strain with MIC 0.5 μg/mL and high value of selectivity index (SI). Compound 3h with the highest SI (1268.58) was used for stability evaluation with putative metabolites (ciprofloxacin and formylciprofloxacin) detection. Compound 3h was stable at pH 7.4 of aqueous buffer and rat plasma, in acidic buffers (at pH 3 and 5) slow decomposition was observed. Interestingly, no formylciprofloxacin was detected in the solution, and only slightly increased concentration of ciprofloxacin was observed instead. Trifluoromethyl hydrazones 3f and 3g exhibited the best activity also against two strains of Mycobacterium kansasii (MIC 1-4 μmol/L). All evaluated compounds were found to be non-cytotoxic.
Tetrahedron | 1990
Vladimir Kepe; Marijan Kočevar; Solvenko Polanc; Bojan Verc̈ek; Miha Tis̈ler
Abstract A general one-pot synthesis of some 2H-pyran-2-ones and fused pyran-2-ones starting from 1,3-dlcarbonyl compounds, N-acylglycines and one-carbon synthons (trialkyl orthoformates, diethoxymethyl acetate or N,N-dlmethylformamide dimethyl acetal) in acetic anhydride (or in a mixture of acetic anhydride and acetic acid) is described.
Bioorganic & Medicinal Chemistry | 2010
Bojan Burja; Tamara Čimbora-Zovko; Sanja Tomić; Tihana Jelušić; Marijan Kočevar; Slovenko Polanc; Maja Osmak
A series of pyrazolone-fused combretastatins and precursors were synthesized and their cytotoxicity as well as antitubulin potential was evaluated. The hydrazide 9f and the pyrazolone-fused combretastatins 12a, 12b and 12c were highly cytotoxic against various tumor cell lines including cisplatin resistant cells. The same compounds were also the best inhibitors of tubulin polymerization. Molecular modeling results showed that they bind the colchicine binding site at the tubulin heterodimer. The hydrazide 9f arrested HeLa cells in the G2/M phase of the cell cycle and strongly affected cell shape and microtubule network.
European Journal of Medicinal Chemistry | 2011
Eva Vavříková; Slovenko Polanc; Marijan Kočevar; Janez Košmrlj; Kata Horváti; Szilvia Bősze; Jiřina Stolaříková; Aleš Imramovský; Jarmila Vinšová
A series of new isoniazid hydrazones was synthesized by two procedures. In the first isoniazid was activated with diethoxymethyl acetate and condensed with the appropriate anilines. Alternatively, substituted anilines were activated by diethoxymethyl acetate and subsequently condensed with isoniazid. NMR study confirmed that both synthetic approaches gave the same tautomer. All compounds were screened for in vitro antimycobacterial activity. Most of them exhibited the same activity against Mycobacterium tuberculosis (MIC 1 μmol L(-1)) as isoniazid (INH), better activity against Mycobacterium kansasii 325/80 (MIC 0.125-0.250 μmol L(-1)), high value of selectivity index (SI) and IC(50) between 0.0218 and 0.326 mmol L(-1). Compound 2o with the best SI was used as a model compound for the stability test and was found to be stable at neutral pH, but under acidic conditions it slowly hydrolysed.
Synthetic Communications | 1989
Marijan Kočevar; Slovenko Polanc; M. Tisler; Bojan Vercek
Abstract A new simple “one-pot” synthesis of some 3-benzoylamino-5-oxo-5, 6, 7, 8-tetrahydrocoumarins from 1, 3-cyclohexanediones, hippuric acid, acetic anhydride and triethyl orthoformate or other one-carbon synthetic equivalent is described.
Heterocycles | 1992
Marijan Kočevar; Vladimir Kepe; Andrej Petrič; Slovenko Polanc; Bojan Vercek
Treatment of 4-ethoxymethylene-2-phenyl-5(4H)-oxazolone with activated methylene compounds under acidic or basic conditions leads to 2H-pyran-2-ones and fused pyran-2-ones. On the other hand, methyl (3-benzoylamino-5-methoxycarbonyl-2-oxo-2H-pyran-6-yl)-acetate (4) has also been prepared by a one-pot synthesis from dimethyl 1,3-acetonedicarboxylate, diethoxymethyl acetate, hippuric acid and acetic anhydride
Chemical Communications | 2002
Sergeja Bombek; Roman Lenaršič; Marijan Kočevar; Laurent Saint-Jalmes; Jean-Roger Desmurs; Slovenko Polanc
An electrophilic amination of halogenated phenols with diisopropyl diazenedicarboxylate in the presence of ZrCl4 as a Lewis acid, accompanied by a halogen migration, was demonstrated for the first time; the fluorine, chlorine, bromine, or iodine atom migrated during the amination process under mild reaction conditions.
Tetrahedron Letters | 1999
Bogdan Štefane; Marijan Kočevar; Slovenko Polanc
Abstract Hydrazides were treated with ceric(IV) ammonium nitrate (CAN) in the presence of the appropriate alcohol as a nucleophile to afford esters in good yields. Reactions took place exclusively at the hydrazino moiety even when other sensitive groups were present in either of the partners.
Heterocycles | 1990
Marijan Kočevar; Slovenko Polanc; M. Tisler; Bojan Vercek
3-Benzoylamino-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydrocoumarin (1a) was used as a synthon in the preparation of the first derivatives of the pyrano[3,2-c]azepine system 2 and in two approaches to pyrido[3,2-c]azepines 4
Tetrahedron | 1998
Biserka Mlakar; Bogdan Štefane; Marijan Kočevar; Slovenko Polanc
A general method for the synthesis of pyrimidine N-oxides from the appropriate carboxamide oximes is described. The conversion involves a treatment of various carboxamide oximes with either 1,1,3,3-tetramethoxypropane, 2,4-pentanedione, 3-ethoxy-2-propenal, 4,4-dimethoxy-2-butanone or 4-methoxy-3-butene-2-one in the presence of trifluoroacetic acid as a catalyst. The application of an unsymmetrical dicarbonyl compound leads exclusively to one product. Our approach is a method of choice for the preparation of pyridylpyrimidine N-oxides.